{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"1084.99","value":"2647.5"}]}],"title":"Cmax at Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"809.61","value":"2258.8"}]}],"title":"Cmax at Day 29"}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"}],"units":"Participants"}],"description":"Cmax at Days 1 and 29 was analyzed. Cmax is defined as the maximum concentration of drug.","dispersionType":"Standard Deviation","groups":[{"description":"Idelalisib 150 mg tablet administered orally twice daily until tumor progression or development of unacceptable toxicity.","id":"OG000","title":"Idelalisib"}],"paramType":"MEAN","populationDescription":"Participants in the PK Analysis Set with available data were analyzed.","reportingStatus":"POSTED","timeFrame":"Predose and at 0.5, 1, 1.5, 2, 3, 4, 6, 8, 10, and 12 hours postdose on Days 1 and 29","title":"PK Parameter: Cmax","type":"SECONDARY","unitOfMeasure":"ng/mL"}